Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia

References

• McCrae K. Immune thrombocytopenia: no longer ‘idiopathic’. Cleve Clin J Med. 2011;78(6):358–373. doi:10.3949/ccjm.78gr.10005
   PubMedGoogle Scholar
• Cines DB, McMillan R. Pathogenesis of chronic immune thrombocytopenic purpura. Curr Opin Hematol. 2007;14(5):511–514. doi:10.1097/MOH.0b013e3282ba5552
   PubMed Web of Science ®Google Scholar
• Imbach P, Lazarus A, Kühne T. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders. Vox Sang. 2010;98(3 p2):385–394. doi:10.1111/j.1423-0410.2009.01264.x
   PubMed Web of Science ®Google Scholar
• Moulis G, Palmaro A, Montastruc J-L, Godeau B, Lapeyre-Mestre M, Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014;124(22):3308–3315. doi:10.1182/blood-2014-05-578336
   PubMed Web of Science ®Google Scholar
• Iraqi M, Perdomo J, Yan F, Choi PY, Chong BH. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Haematologica. 2015;100(5):623. doi:10.3324/haematol.2014.115634
   PubMed Web of Science ®Google Scholar
• Marieke Schoonen W, Kucera G, Coalson J, et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145(2):235–244. doi:10.1111/j.1365-2141.2009.07615.x
   PubMed Web of Science ®Google Scholar
• Douglas B, Cines HL, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46:S2–S14. doi:10.1053/j.seminhematol.2008.12.005
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113(26):6511–6521.
   PubMed Web of Science ®Google Scholar
• Frederiksen H, Maegbaek ML, Nørgaard M. Twenty‐year mortality of adult patients with primary immune thrombocytopenia: a Danish population‐based cohort study. Br J Haematol. 2014;166(2):260–267. doi:10.1111/bjh.12869
   PubMed Web of Science ®Google Scholar
• Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381(10):945–955. doi:10.1056/NEJMcp1810479
   PubMed Web of Science ®Google Scholar
• Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168–186. doi:10.1182/blood-2009-06-225565
   PubMed Web of Science ®Google Scholar
• Piel-Julian ML, Mahevas M, Germain J, et al. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults. J Thromb Haemost. 2018;16(9):1830–1842. doi:10.1111/jth.14227
   PubMed Web of Science ®Google Scholar
• Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. ArchInternMed. 2000;160(11):1630–1638.
   Google Scholar
• Neunert C, Lim W, Crowther M, Cohen A, Solberg JL, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190–4207. doi:10.1182/blood-2010-08-302984
   PubMed Web of Science ®Google Scholar
• ITP A, British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120(4):574–596. doi:10.1046/j.1365-2141.2003.04131.x
   PubMed Web of Science ®Google Scholar
• Stasi R, Provan D. Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc. 2004;79(4):504–522. doi:10.4065/79.4.504
   PubMed Web of Science ®Google Scholar
• Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017;129(21):2829–2835. doi:10.1182/blood-2017-03-754119
   PubMed Web of Science ®Google Scholar
• Fogarty PF. Chronic immune thrombocytopenia in adults: epidemiology and clinical presentation. Hematol Oncol Clin North Am. 2009;23(6):1213–1221. doi:10.1016/j.hoc.2009.08.004
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–2393. doi:10.1182/blood-2008-07-162503
   PubMed Web of Science ®Google Scholar
• Moulis G, Lapeyre-Mestre M, Montastruc J-L, Sailler L. Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study. Autoimmun Rev. 2015;14(2):168–173. doi:10.1016/j.autrev.2014.10.017
   PubMed Web of Science ®Google Scholar
• Palandri F, Polverelli N, Sollazzo D, et al. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years. Am J Hematol. 2016;91(4):E267–E272. doi:10.1002/ajh.24310
   PubMed Web of Science ®Google Scholar
• Chaturvedi S, Arnold DM, McCrae KR. Splenectomy for immune thrombocytopenia: down but not out. Blood. 2018;131(11):1172–1182. doi:10.1182/blood-2017-09-742353
   PubMed Web of Science ®Google Scholar
• Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780–3817. doi:10.1182/bloodadvances.2019000812
   PubMed Web of Science ®Google Scholar
• Michel M. Immune thrombocytopenia nomenclature, consensus reports, and guidelines: what are the consequences for daily practice and clinical research? Semin Hematol. 2013;50(Suppl 1):S50–S54. doi:10.1053/j.seminhematol.2013.03.008
   PubMedGoogle Scholar
• George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(1):3–40. doi:10.1182/blood.V88.1.3.3
   PubMed Web of Science ®Google Scholar
• Christiansen CF, Bahmanyar S, Ghanima W, et al. Chronic immune thrombocytopenia in Denmark, Sweden and Norway: the Nordic country patient registry for romiplostim. EClinicalMedicine. 2019;14:80–87. doi:10.1016/j.eclinm.2019.07.015
   PubMedGoogle Scholar
• Lamnisos D, Giannakou K, Jakovljevic M. Demographic forecasting of population aging in Greece and Cyprus: one big challenge for the Mediterranean health and social system long-term sustainability. Health Research Policy and Systems. 2021;19(1):21. doi:10.1186/s12961-020-00666-x
   PubMed Web of Science ®Google Scholar
• Kurata Y, Fujimura K, Kuwana M, Tomiyama Y, Murata M. Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review. Int J Hematol. 2011;93(3):329–335. doi:10.1007/s12185-011-0791-1
   PubMed Web of Science ®Google Scholar
• Abrahamson PE, Hall SA, Feudjo-Tepie M, Mitrani-Gold FS, Logie J. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur J Haematol. 2009;83(2):83–89. doi:10.1111/j.1600-0609.2009.01247.x
   PubMed Web of Science ®Google Scholar
• Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85(3):174–180. doi:10.1002/ajh.21616
   PubMed Web of Science ®Google Scholar
• Segal JB, Powe N. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006;4(11):2377–2383. doi:10.1111/j.1538-7836.2006.02147.x
   PubMed Web of Science ®Google Scholar
• Yong M, Schoonen WM, Li L, et al. Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol. 2010;149(6):855–864. doi:10.1111/j.1365-2141.2010.08176.x
   PubMed Web of Science ®Google Scholar
• Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829–3866. doi:10.1182/bloodadvances.2019000966
   PubMed Web of Science ®Google Scholar
• Schulze H, Gaedicke G. Immune thrombocytopenia in children and adults: what’s the same, what’s different? Haematologica. 2011;96(12):1739–1741. doi:10.3324/haematol.2011.055830
   PubMed Web of Science ®Google Scholar
• Wong GC, Lee LH. A study of idiopathic thrombocytopenic purpura (ITP) patients over a ten-year period. Ann Acad Med Singap. 1998;27(6):789–793.
   PubMedGoogle Scholar
• Doan CA, Bouroncle BA, Wiseman BK. Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Inter Med. 1960;53(5):861–876.
   Web of Science ®Google Scholar
• George J. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: Williams Hematology. McGraw-Hill; 1995:1315–1355.
   Google Scholar
• Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999;94(3):909–913. doi:10.1182/blood.V94.3.909.415k02_909_913
   PubMed Web of Science ®Google Scholar
• Michel M, Suzan F, Adoue D, et al. Management of immune thrombocytopenia in adults: a population‐based analysis of the French hospital discharge database from 2009 to 2012. Br J Haematol. 2015;170(2):218–222. doi:10.1111/bjh.13415
   PubMed Web of Science ®Google Scholar
• Lee JY, Lee J-H, Lee H, et al. Epidemiology and management of primary immune thrombocytopenia: a nationwide population-based study in Korea. Thromb Res. 2017;155:86–91. doi:10.1016/j.thromres.2017.05.010
   PubMed Web of Science ®Google Scholar
• Hung GY, Lee CY, Yen HJ, Lin LY, Horng JL. Incidence of immune thrombocytopenia in Taiwan: a nationwide population-based study. Transfusion. 2018;58(11):2712–2719. doi:10.1111/trf.14915
   PubMed Web of Science ®Google Scholar
• Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol. 2000;124(1):71–81.
   Google Scholar
• Miyakis S, Lockshin M, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306. doi:10.1111/j.1538-7836.2006.01753.x
   PubMed Web of Science ®Google Scholar
• Kelton JG, Vrbensky JR, Arnold DM. How do we diagnose immune thrombocytopenia in 2018? Hematology Am Soc Hematol Educ Program. 2018;2018(1):561–567. doi:10.1182/asheducation-2018.1.561
   PubMed Web of Science ®Google Scholar
• Goh K-L, Parasakthi N. The racial cohort phenomenon: seroepidemiology of Helicobacter pylori infection in a multiracial South-East Asian country. Eur J Gastroenterol Hepatol. 2001;13(2):177–183. doi:10.1097/00042737-200102000-00014
   PubMed Web of Science ®Google Scholar
• Goh KL. Epidemiology of Helicobacter pylori infection in Malaysia–observations in a multiracial Asian population. Med J Malaysia. 2009;64(3):187–192.
   PubMedGoogle Scholar
• Arnold DM, Bernotas A, Nazi I, et al. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica. 2009;94(6):850. doi:10.3324/haematol.2008.005348
   PubMed Web of Science ®Google Scholar
• Stasi R, Sarpatwari A, Segal JB, et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009;113(6):1231–1240.
   PubMed Web of Science ®Google Scholar
• Arnold DM, Nazy I, Clare R, et al. Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP registry. Blood Adv. 2017;1(25):2414–2420. doi:10.1182/bloodadvances.2017010942
   PubMed Web of Science ®Google Scholar
• Ko B-S, Wu GH-M, Wang Y-C, et al. Demographics and long-term outcome of incident immune thrombocytopenic purpura: a twelve-years nationwide population-based study in Taiwan. Blood. 2015;126(23):3259. doi:10.1182/blood.V126.23.3259.3259
   Web of Science ®Google Scholar
• Moulis G, Germain J, Comont T, et al. Newly diagnosed immune thrombocytopenia adults: clinical epidemiology, exposure to treatments, and evolution. results of the CARMEN multicenter prospective cohort. Am J Hematol. 2017;92(6):493–500. doi:10.1002/ajh.24702
   PubMed Web of Science ®Google Scholar
• Sadia Sultan F, Ahmed SI, Murad S, Irfan SM. Primary versus secondary immune thrombocytopenia in adults; a comparative analysis of clinical and laboratory attributes in newly diagnosed patients in Southern Pakistan. Med J Malaysia. 2016;71(5):269.
   PubMedGoogle Scholar
• Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR, Group NRH. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patients. Br J Haematol. 2003;122(6):966–974. doi:10.1046/j.1365-2141.2003.04547.x
   PubMed Web of Science ®Google Scholar
• Doobaree U, Nandigam R, Newland A, Provan D. The United Kingdom immune thrombocytopenia (UK-ITP) registry: preliminary findings on bleeding events experienced by its participants. Haematologica. 2015;100(S1):303.
   Google Scholar
• Cuker A, Cines DB. Immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2010;2010(1):377–384. doi:10.1182/asheducation.V2010.1.377.3643150
   PubMedGoogle Scholar
• Neunert C, Noroozi N, Norman G, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost. 2015;13(3):457–464. doi:10.1111/jth.12813
   PubMed Web of Science ®Google Scholar
• Kühne T, Berchtold W, Michaels LA, et al. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica. 2011;96(12):1831. doi:10.3324/haematol.2011.050799
   PubMed Web of Science ®Google Scholar
• Stasi R, Stipa E, Masi M, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98(5):436–442. doi:10.1016/S0002-9343(99)80342-8
   PubMed Web of Science ®Google Scholar
• Vianelli N, Valdrè L, Fiacchini M, et al. Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. Haematologica. 2001;86(5):504–509.
   PubMed Web of Science ®Google Scholar
• Grimaldi-Bensouda L, Nordon C, Michel M, et al. Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome. Haematologica. 2016;101(9):1039. doi:10.3324/haematol.2016.146373
   PubMed Web of Science ®Google Scholar
• Khellaf M, Michel M, Schaeffer A, Bierling P, Godeau B. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica. 2005;90(6):829–832.
   PubMed Web of Science ®Google Scholar
• Matzdorff A, Meyer O, Ostermann H, et al. Immune thrombocytopenia - current diagnostics and therapy: recommendations of a joint working group of DGHO, ÖGHO, SGH, GPOH, and DGTI. Oncol Res Treat. 2018;41(suppl 5):1–30. doi:10.1159/000492187
   PubMed Web of Science ®Google Scholar
• Heng LL, Caguioa P, Chin NS, et al. Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region. Int J Hematol. 2011;94(2):142–149. doi:10.1007/s12185-011-0894-8
   PubMed Web of Science ®Google Scholar
• Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1(24):2295–2301. doi:10.1182/bloodadvances.2017009860
   PubMed Web of Science ®Google Scholar
• Song F, Al-Samkari H. Management of adult patients with Immune Thrombocytopenia (ITP): a review on current guidance and experience from clinical practice. J Blood Med. 2021;12:653–664. doi:10.2147/JBM.S259101
   PubMed Web of Science ®Google Scholar
• Cooper N, Kruse A, Kruse C, et al. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Am J Hematol. 2021;96(2):188–198. doi:10.1002/ajh.26045
   PubMed Web of Science ®Google Scholar
• Kuter DJ, Macahilig C, Grotzinger KM, et al. Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim. Int J Hematol. 2015;101(3):255–263. doi:10.1007/s12185-014-1731-7
   PubMed Web of Science ®Google Scholar
• Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med. 2007;357(22):2237–2247. doi:10.1056/NEJMoa073275
   PubMed Web of Science ®Google Scholar
• Nurden AT, Viallard J-F, Nurden P. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura. Lancet. 2009;373(9674):1562–1569. doi:10.1016/S0140-6736(09)60255-5
   PubMed Web of Science ®Google Scholar
• Shirasugi Y, Ando K, Hashino S, et al. A Phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura. Int J Hematol. 2009;90(2):157–165. doi:10.1007/s12185-009-0361-y
   PubMed Web of Science ®Google Scholar
• Giordano P, Lassandro G, Barone A, et al. Use of eltrombopag in children with chronic Immune Thrombocytopenia (ITP): a real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Front Med. 2020;7:66.
   PubMed Web of Science ®Google Scholar
• Kueh Y. Adult idiopathic thrombocytopenic purpura. Singapore Med J. 1995;36(4):367–370.
   PubMedGoogle Scholar
• Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97(9):2549–2554. doi:10.1182/blood.V97.9.2549
   PubMed Web of Science ®Google Scholar
• Khadka S, Kasireddy V, Dhakal PK, Dadiboyina C. Evolving treatment modalities for immune thrombocytopenia in adults. J Community Hosp Intern Med Perspect. 2021;11(1):115–119. doi:10.1080/20009666.2020.1843237
   PubMed Web of Science ®Google Scholar